[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours

Insulin-like Growth Factor-I Receptor/Human Epidermal Growth Factor Receptor 2 Heterodimerization Contributes to Trastuzumab Resistance of Breast Cancer Cells

Rita Nahta, Linda X.H. Yuan, Bing Zhang et al. · Cancer Research · 2005 · 801 citations

Medicine, Cancer Biology, Oncology +17

R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

Alberto S. Pappo, Shreyaskumar Patel, John Crowley et al. · Journal of Clinical Oncology · 2011 · 321 citations

Medicine, Oncology, Immunotherapy +16

Molecular Imaging of <i>HER2</i>-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic ¹¹¹In- or ⁶⁸Ga-Labeled Affibody Molecules

Richard P. Baum, Vikas Prasad, Dirk Müller et al. · Journal of Nuclear Medicine · 2010 · 307 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer

Lyndsay N. Harris, Fanglei You, Stuart J. Schnitt et al. · Clinical Cancer Research · 2007 · 243 citations

Medicine, Oncology, Pharmacology +17

Correction: IGF-IR/HER-2 Contributes to Trastuzumab Resistance

Cancer Research · 2008 · 231 citations

Medicine, Cancer Biology, Molecular Medicine +12